Determination of 5-S-cysteinyldopa in plasma and urine using a fully automated solid-phase extraction--high-performance liquid chromatographic method for an improvement of specificity and sensitivity of this prognostic marker of malignant melanoma. [electronic resource]
- Journal of chromatography. B, Biomedical sciences and applications Apr 1999
- 31-42 p. digital
Publication Type: Journal Article
1387-2273
10.1016/s0378-4347(99)00098-5 doi
Automation Biomarkers, Tumor--blood Calibration Case-Control Studies Chromatography, High Pressure Liquid--methods Cysteinyldopa--blood Humans Melanoma--blood Prognosis Reference Standards Reproducibility of Results Sensitivity and Specificity Skin Neoplasms--blood